Results 171 to 180 of about 1,032,345 (337)
Anti-CNS antibodies in neurological and psychiatric disorders. [PDF]
Audrius V. Plioplys+4 more
openalex +1 more source
Annals of Clinical and Translational Neurology, EarlyView.
Sergi Borrego‐Écija+3 more
wiley +1 more source
CSF Mitochondrial DNA: Biomarker of Body Composition and Energy Metabolism in Parkinson's Disease
ABSTRACT Objective Cerebrospinal fluid (CSF) cell‐free mitochondrial DNA (cf‐mtDNA) is a potential biomarker for Parkinson's disease (PD), but its clinical relevance remains unclear. We investigated associations between CSF cf‐mtDNA levels, body composition, nutritional status, and metabolic biomarkers in PD. Methods CSF cf‐mtDNA levels, defined as the
Yasuaki Mizutani+11 more
wiley +1 more source
Clock-Drawing in Neurological Disorders [PDF]
Gerald J. Dal Pan+3 more
openalex +1 more source
ABSTRACT Background Managing long COVID in people with multiple sclerosis and related disorders (pwMSRD) is complex due to overlapping symptoms. To address evidence gaps, we evaluated long COVID susceptibility in pwMSRD versus controls and its associations with multi‐domain function and disability.
Chen Hu+15 more
wiley +1 more source
42. Study on the Brain Biopsy in Neurological Disorders of Children
Hirota Horinouchi+4 more
openalex +2 more sources
Analysis of Soluble Interleukin‐2 Receptor as a Prognostic Biomarker in NMOSD and MOGAD
ABSTRACT Objective Soluble interleukin‐2 receptor (sIL‐2R) is a biomarker for T cell activity. T cells are involved in neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) pathogenesis. However, sIL‐2R has so far not been evaluated in these conditions.
Philipp Klyscz+8 more
wiley +1 more source
Immunoglobulins in cerebrospinal fluid in various neurologic disorders. [PDF]
A Bouloukos+3 more
openalex +1 more source